4.2 Article

WHICH CRITERIA ARE CONSIDERED IN HEALTHCARE DECISIONS? INSIGHTS FROM AN INTERNATIONAL SURVEY OF POLICY AND CLINICAL DECISION MAKERS

Journal

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0266462313000573

Keywords

Criteria; Decision making; Priority setting; Multicriteria; Health care

Funding

  1. Canadian Institutes of Health Research (CIHR) [228208]

Ask authors/readers for more resources

Objectives: The aim of this study was to gather qualitative and quantitative data on criteria considered by healthcare decision makers. Methods: Using snowball sampling and an online questionnaire with forty-three criteria organized into ten clusters, decision makers were invited by an international task force to report which criteria they consider when making decisions on healthcare interventions in their context. Respondents reported whether each criterion is currently considered, should be considered, and its relative weight (scale 0-5). Differences in proportions of respondents were explored with inferential statistics across levels of decision (micro, meso, macro), decision maker perspectives, and world regions. Results: A total of 140 decision makers (1/3 clinical, 2/3 policy) from 23 countries in five continents completed the survey. The most relevant criteria (top ranked for Currently considered, Should be considered, and weights) were Clinical efficacy/effectiveness, Safety, Quality of evidence, Disease severity, and Impact on healthcare costs. Organizational and skill requirements were frequently considered but had relatively low weights. For almost all criteria, a higher proportion of decision makers reported that they Should be considered than that they are Currently considered (p < .05). For more than 74 percent of criteria, there were no statistical differences in proportions across levels of decision, perspectives and world regions. Statistically significant differences across several comparisons were found for: Population priorities, Stakeholder pressure/interests, Capacity to stimulate research, Impact on partnership and collaboration, and Environmental impact. Conclusions: Results suggest convergence among decision makers on the relevance of a core set of criteria and on the need to consider a wider range of criteria. Areas of divergence appear to be principally related to contextual factors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Economics

Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries

Rudy Douven, Lukas Kauer, Sylvia Demme, Francesco Paolucci, Wynand van de Ven, Juergen Wasem, Xiaoxi Zhao

Summary: Most countries focus on risk-equalization of medical claims in their health insurance market, while neglecting administrative costs. This study finds that health insurers with a high morbidity population tend to have higher administrative costs. The authors argue for the inclusion of administrative costs in risk-equalization, and demonstrate the practical implementation using examples from Germany and the US. They remain skeptical about extending risk-equalization to other components of the insurance premium.

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2022)

Article Business, Finance

Designing feasible and effective health plan payments in countries with data availability constraints

Josefa Henriquez, Marica Iommi, Thomas McGuire, Emmanouil Mentzakis, Francesco Paolucci

Summary: Risk equalization schemes and risk sharing are fundamental tools in regulated health insurance markets, aiming to reduce risks for insurers. This paper proposes a method of incorporating risk sharing within a risk equalization scheme in a data-poor context, and demonstrates its effectiveness through a case study of Chile's private health insurance market.

JOURNAL OF RISK AND INSURANCE (2023)

Article Business, Finance

Can risk rating increase the ability of voluntary deductibles to reduce moral hazard?

M. Antonini, R. C. van Kleef, J. Henriquez, F. Paolucci

Summary: This paper examines the potential reduction in moral hazard from a voluntary deductible under risk-rated premiums, using Chile as a case study. The findings suggest that under risk-rated premiums, the absolute reduction in moral hazard from a voluntary deductible is expected to be larger compared to a system with community-rated premiums.

GENEVA PAPERS ON RISK AND INSURANCE-ISSUES AND PRACTICE (2023)

Article Multidisciplinary Sciences

Applying machine learning and predictive modeling to retention and viral suppression in South African HIV treatment cohorts

Mhairi Maskew, Kieran Sharpey-Schafer, Lucien De Voux, Thomas Crompton, Jacob Bor, Marcus Rennick, Admire Chirowodza, Jacqui Miot, Seithati Molefi, Chuka Onaga, Pappie Majuba, Ian Sanne, Pedro Pisa

Summary: This study applied predictive machine learning algorithms to HIV programmatic data from South Africa and developed models to predict patient attendance and viral load suppression. Important predictors included previous visit history, viral load testing frequency, visit time, age, and treatment duration. The results showed that machine learning can effectively identify HIV patients at risk of disengagement and unsuppressed viral load.

SCIENTIFIC REPORTS (2022)

Article Business, Finance

The interplay between risk adjustment and risk rating in voluntary health insurance

Peter Paul Klein, Richard van Kleef, Josefa Henriquez, Francesco Paolucci

Summary: This paper examines the interaction between risk adjustment and risk rating in the context of voluntary health insurance markets in Chile, Ireland, and Australia.

JOURNAL OF RISK AND INSURANCE (2023)

Article Health Care Sciences & Services

Progress towards unique patient identification and case-based surveillance within the Southern African development community

Kerensa Govender, Lawrence Long, Jacqui Miot

Summary: Population mobility poses challenges for patient tracking and care coordination in the South African Development Community (SADC). Case-based surveillance (CBS) using individual-level clinical data linked with a unique patient identifier (UPI) is recommended. We conducted a mixed-methods landscape analysis of UPI and CBS implementation in SADC countries and found that research in this area is lacking. Existing patient identification methods are often ineffective and hinder patient tracking. The implementation of UPI and CBS in most SADC countries is still at an early-middle stage and faces challenges.

HEALTH INFORMATICS JOURNAL (2023)

Article Economics

An Economic Model for Estimating Trial Costs with an Application to Placebo Surgery Trials

Chris Schilling, Michelle Tew, Samantha Bunzli, Cade Shadbolt, L. Stefan Lohmander, Zsolt J. Balogh, Francesco Paolucci, Peter F. Choong, Michelle M. Dowsey, Philip Clarke

Summary: This study developed an economic model to predict the cost of clinical trials based on various factors. It found that successful trials accurately predicted their recruitment rate, while those that overestimated it were more likely to fail. Overestimating recruitment rates led to significantly higher costs, highlighting the need for better planning, reviewing, and funding of clinical trials to avoid costly overruns and incomplete trials.

APPLIED HEALTH ECONOMICS AND HEALTH POLICY (2023)

Article Health Policy & Services

Standardising policy and technology responses in the immediate aftermath of a pandemic: a comparative and conceptual framework

Naomi Moy, Marcello Antonini, Mattias Kyhlstedt, Gianluca Fiorentini, Francesco Paolucci

Summary: This study proposes a conceptual framework to compare the effectiveness of government interventions in different countries during the COVID-19 pandemic. By comparing Italy, New Zealand, the United Kingdom, and the United States, it is found that the intensity and extent of policy measures have dynamic impacts on pandemic and economic outcomes. The framework can help decision-makers evaluate the effects of different policies on health and non-health outcomes during a pandemic.

HEALTH RESEARCH POLICY AND SYSTEMS (2023)

Article Health Care Sciences & Services

Cost and outcomes of routine HIV care and treatment: public and private service delivery models covering low-income earners in South Africa

L. C. Long, S. Girdwood, K. Govender, G. Meyer-Rath, J. Miot

Summary: This study evaluated innovative private sector models for HIV treatment in South Africa and compared their costs and outcomes with government primary health clinics. The results showed that there were variations in costs and outcomes among the private sector models, but some models had similar results to the public sector. Therefore, offering HIV treatment through private delivery models under National Health Insurance (NHI) could be an option to increase access beyond the current public sector capacity.

BMC HEALTH SERVICES RESEARCH (2023)

Review Health Care Sciences & Services

Interventions for improving clinical outcomes and health-related quality-of-life for people living with skeletal dysplasias: an evidence gap map

Naomi Moy, Darren Flynn, Josefa Henriquez, Luke B. Connelly, Luke Vale, Francesco Paolucci

Summary: The purpose of this paper was to develop an evidence-gap map of treatment options for skeletal dysplasias and their impact on patient outcomes. A systematic search identified 58 studies, most of which focused on the effects of height reduction treatments. However, there is still a lack of research on treatment options, outcomes, and the lived experience of patients with other skeletal dysplasias.

QUALITY OF LIFE RESEARCH (2023)

Article Business, Finance

Priority setting in the German healthcare system: results from a discrete choice experiment

V. Meusel, E. Mentzakis, P. Baji, G. Fiorentini, F. Paolucci

Summary: Worldwide, social healthcare systems are facing the challenges of limited resources and their equitable distribution. In Germany, there is a need for more systematic priority setting procedures, and multi-criteria decision analysis (MCDA) has been identified as a promising approach. This study analyzed the preferences of German decision makers in setting priority interventions, showing a higher preference for efficiency criteria and highlighting mental disorders and cardiovascular diseases as high priority interventions.

INTERNATIONAL JOURNAL OF HEALTH ECONOMICS AND MANAGEMENT (2023)

Article Health Care Sciences & Services

Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi

Lucky G. G. Ngwira, Hendramoorthy Maheswaran, Janine Verstraete, Stavros Petrou, Louis Niessen, Sarah C. C. Smith

Summary: The psychometric performance of the EQ-5D-Y-3L and EQ-5D-Y-5L was evaluated in this study. Both versions had issues with missing data in younger children. Convergent validity, discriminant validity with respect to gender and age, and known-group validity were met for both measures, although with some limitations. The EQ-5D-Y-5L was less efficient than the EQ-5D-Y-3L in detecting differences in health status.

JOURNAL OF PATIENT-REPORTED OUTCOMES (2023)

Article Health Care Sciences & Services

Role Preferences in Medical Decision Making: Relevance and Implications for Health Preference Research

Janine A. van Til, Alison Pearce, Semra Ozdemir, Ilene L. Hollin, Holly L. Peay, Albert W. Wu, Jan Ostermann, Ken Deal, Benjamin M. Craig

Summary: Health preference research should take into account patients' role preferences in medical decision making, and incorporate them in the study design, instrument development, and statistical analysis. Understanding the relationship between role preferences and health preferences is important for medical and shared decision making.

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2023)

No Data Available